First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults

S. Pasquali; Antonella Brunello; Alessandro Gronchi; Samuel Ford; Marco Maruzzo; Marco Rastrelli; S. Mocellin

doi:10.1002/14651858.CD012383

First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults

S. Pasquali, Antonella Brunello, Alessandro Gronchi, Samuel Ford, Marco Maruzzo, Marco Rastrelli, S. Mocellin

Research output: Contribution to journal › Article

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a first-line metastatic setting. To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a second-line metastatic setting. To assess the effects of chemotherapy regimens adapted to specific sarcoma histologies.

Original language	English
Article number	CD012383
Journal	Cochrane Database of Systematic Reviews
Volume	2016
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD012383
Publication status	Published - Oct 12 2016

ASJC Scopus subject areas

Medicine(all)
Pharmacology (medical)

Access to Document

10.1002/14651858.CD012383

Fingerprint Dive into the research topics of 'First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults'. Together they form a unique fingerprint.

Cite this

Pasquali, S., Brunello, A., Gronchi, A., Ford, S., Maruzzo, M., Rastrelli, M., & Mocellin, S. (2016). First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults. Cochrane Database of Systematic Reviews, 2016(10), [CD012383]. https://doi.org/10.1002/14651858.CD012383

@article{799104ea9ec349ad8979b5dcec318ab0,

title = "First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a first-line metastatic setting. To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a second-line metastatic setting. To assess the effects of chemotherapy regimens adapted to specific sarcoma histologies.",

author = "S. Pasquali and Antonella Brunello and Alessandro Gronchi and Samuel Ford and Marco Maruzzo and Marco Rastrelli and S. Mocellin",

year = "2016",

month = oct,

day = "12",

doi = "10.1002/14651858.CD012383",

language = "English",

volume = "2016",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults

AU - Pasquali, S.

AU - Brunello, Antonella

AU - Gronchi, Alessandro

AU - Ford, Samuel

AU - Maruzzo, Marco

AU - Rastrelli, Marco

AU - Mocellin, S.

PY - 2016/10/12

Y1 - 2016/10/12

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a first-line metastatic setting. To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a second-line metastatic setting. To assess the effects of chemotherapy regimens adapted to specific sarcoma histologies.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a first-line metastatic setting. To assess the effects of systemic therapy for the treatment of metastatic soft tissue sarcomas in a second-line metastatic setting. To assess the effects of chemotherapy regimens adapted to specific sarcoma histologies.

UR - http://www.scopus.com/inward/record.url?scp=84991270478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991270478&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012383

DO - 10.1002/14651858.CD012383

M3 - Article

VL - 2016

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 10

M1 - CD012383

ER -